These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gut microbiota does not play a mediating role in the causal association between inflammatory bowel disease and several its associated extraintestinal manifestations: a Mendelian randomization study. Lu W, Cen J, Dai Q, Tao H, Peng L. Front Immunol; 2023; 14():1296889. PubMed ID: 38288127 [Abstract] [Full Text] [Related]
13. Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations. Liu D, Cao M, Wang H, Cao W, Zheng C, Li Y, Wang Y. BMC Med; 2024 Mar 25; 22(1):137. PubMed ID: 38528540 [Abstract] [Full Text] [Related]
17. Associations of inflammatory cytokines with inflammatory bowel disease: a Mendelian randomization study. Song Z, Li X, Xie J, Han F, Wang N, Hou Y, Yao J. Front Immunol; 2023 Mar 25; 14():1327879. PubMed ID: 38288119 [Abstract] [Full Text] [Related]
18. The genetically predicted causal relationship of inflammatory bowel disease with bone mineral density and osteoporosis: evidence from two-sample Mendelian randomization. Xu D, Chen Y, Gao X, Xie W, Wang Y, Shen J, Yang G, Xie B. Front Immunol; 2023 Mar 25; 14():1148107. PubMed ID: 37275908 [Abstract] [Full Text] [Related]
19. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants. Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Epidemiology; 2017 Jan 25; 28(1):30-42. PubMed ID: 27749700 [Abstract] [Full Text] [Related]